Searchable abstracts of presentations at key conferences in endocrinology

ea0086p246 | Neuroendocrinology and Pituitary | SFEBES2022

A novel presentation of primary hyperparathyroidism for the Val804Met mutation

Yadav Jahnavi , Mehta Rubin , Avari Parizad , Freudenthal Bernard , Mulla Kaenat , Mistry Kieran , MacEacharn William , Cox Jeremy

Background: Multiple endocrine neoplasia type 2 (MEN2) is a group of pleomorphic syndromes which infer a susceptibility to several endocrine conditions. The RET Val804Met mutation is classified as a moderate-risk mutation for familial medullary thyroid cancer (MTC), without the other components of MEN2 syndromes. However, here we describe a rare case of a gentleman with RET p.V804M, presenting with primary hyperparathyroidism (PHPT) and no evidence of MTC.<p class="abstext...

ea0086cc3 | Featured Clinical Case Posters | SFEBES2022

Transient hypophosphatemia secondary to iron infusion

Mistry Kieran , MacEacharn William , Yadav Jahnavi , Mehta Rubin , Mulla Kaenat , Freudenthal Bernard , Avari Parizad , Cox Jeremy , Vakilgilani Tannaz

Hypophosphatemia is commonly missed due to nonspecific signs and symptoms. It can cause muscle weakness, confusion, white blood cell dysfunction and disrupt cardiopulmonary systems. Three main mechanisms of hypophosphatemia are shifts from the extracellular to intracellular compartment, increased renal excretion and decreased intestinal absorption. Here we report a case of symptomatic hypophosphatemia post ferric carboxymaltose (Ferrinject) infusion. A 42 year old lady with lo...